Fundraising Fox
🦊/People
Sign in

Maha Radhakrishnan

Investor

Executive Partner, Private Equity at Sofinnova Ventures · Director at Claris Biotherapeutics

Find your path to Maha

55 people in our graph share verified history with Maha — schools, employers, funds. One of them is your warm intro.

Jonathan BurbaumunlockedMaha: together at Sofinnova Ventures
×11Maha: together at Sofinnova Ventures

About

Maha Radhakrishnan is an industry executive with decades of experience in product development, commercialization, and global medical strategy across biotechnology and pharmaceutical companies. Before joining Sofinnova in 2024, she served as Consultant to the CEO at Dyne Therapeutics, Chief Medical Officer at Biogen, and Senior Vice President and Global Head of Medical for the Primary Care Business Unit at Sanofi, with earlier leadership roles at Bioverativ, Bristol Myers Squibb, United Health Group, and Cephalon. She holds an M.D. in internal medicine from the People's Friendship University in Moscow and a master's degree in Russian language.

Invests in

Biotech

Director at Claris Biotherapeutics

Intro paths

→

In turn, Maha can intro founders to Claris Biotherapeutics's investors below.

Claris Biotherapeutics's investors · 4

Catalio Capital ManagementNew YorkNovo HoldingsCopenhagen · $1.1M – $54M checksSamsara BioCapitalPalo AltoSofinnova VenturesMenlo Park · $100K – $15M checks

Investments

Per the firm's website.

Colleagues at Sofinnova Ventures

Alex Chan
Controller, Private Equity at Sofinnova Ventures
Alex Dulnev
IT Manager at Sofinnova Ventures
Amanda Phillips
Executive Assistant at Sofinnova Ventures
Anastasia Voevodin
Analyst, Public Equity at Sofinnova Ventures
Aneal Tenjarla
Partner, Associate Portfolio Manager, Public Equity at Sofinnova Ventures
Calvin Sternick
Analyst, Public Equity at Sofinnova Ventures
Chris Carpenter
Executive Partner, Private Equity at Sofinnova Ventures
David Kabakoff
Executive Partner, Private Equity at Sofinnova Ventures

Frequently asked questions

Who is Maha Radhakrishnan?
Maha Radhakrishnan is an industry executive with decades of experience in product development, commercialization, and global medical strategy across biotechnology and pharmaceutical companies. Before joining Sofinnova in 2024, she served as Consultant to the CEO at Dyne Therapeutics, Chief Medical Officer at Biogen, and Senior Vice President and Global Head of Medical for the Primary Care Business Unit at Sanofi, with earlier leadership roles at Bioverativ, Bristol Myers Squibb, United Health Group, and Cephalon. She holds an M.D. in internal medicine from the People's Friendship University in Moscow and a master's degree in Russian language.
Where does Maha Radhakrishnan work?
Maha Radhakrishnan is Executive Partner, Private Equity at Sofinnova Ventures.
What does Maha Radhakrishnan invest in?
Maha Radhakrishnan invests in Biotech.
What boards does Maha Radhakrishnan sit on?
Maha Radhakrishnan holds tracked board seats at City Therapeutics.